The University of Chicago Header Logo

Connection

Kenneth Gordon to Patient Dropouts

Back to Details
This is a "connection" page, showing publications Kenneth Gordon has written about Patient Dropouts.
Kenneth Gordon
Connection Strength
0.026
Patient Dropouts
  1. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years. Br J Dermatol. 2012 Apr; 166(4):861-72.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.